AAF-CMK

• UNSPSC Description:

  AAF-CMK is a TPPII (tripeptidylpeptidase II) inhibitor, shows anti-tumor activity and induces apoptosis. AAF-CMK can be used in leukemia research[1].

• Target Antigen:

  Apoptosis; Ser/Thr Protease

• Type:

  Peptides

• Related Pathways:

  Apoptosis;Metabolic Enzyme/Protease

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/aaf-cmk.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@H](N)C(N[C@@H](C)C(N[C@H](C(CCl)=O)CC1=CC=CC=C1)=O)=O

• Molecular Weight:

  339.82

• References & Citations:

  [1]Młnarczuk I, et al. AAF-cmk sensitizes tumor cells to trail-mediated apoptosis. Leuk Res. 2004 Jan;28(1):53-61.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  102129-66-8